Catalyst Private Wealth’s Guardant Health GH Stock Holding History

Catalyst Private Wealth’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$22K	–	145
2020 Q3	$22K	Buy	+200	New	+$18.3K	0.02%	162

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Catalyst Private Wealth's GH Position: Q4 2020 in Review

Catalyst Private Wealth sold out of Guardant Health (GH) in Q4 2020, closing a stake of 200 shares — an estimated $22K sold.

Catalyst Private Wealth first reported a position in GH in Q3 2020 and held it in 1 quarter. The position peaked at $22K in Q3 2020. 419 funds tracked by Wall St. Rank hold GH as of Q4 2020.

Catalyst Private Wealth reported no remaining Guardant Health position as of Q4 2020 after selling out during the quarter.
Catalyst Private Wealth sold 200 Guardant Health shares in Q4 2020, an estimated $22K.
Catalyst Private Wealth first reported a position in Guardant Health in Q3 2020 and held it in 1 quarter.
Catalyst Private Wealth's Guardant Health position peaked at $22K in Q3 2020.
419 funds tracked by Wall St. Rank held Guardant Health as of Q4 2020.

Based on Catalyst Private Wealth's 13F filing for Q4 2020, filed 5 Mar 2021.